Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT04187599
NA

Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)

Sponsor: CooperVision International Limited (CVIL)

View on ClinicalTrials.gov

Summary

The main objective of this post market clinical study is to evaluate the effectiveness and safety of the Paragon CRT®100 Contact Lens.

Official title: Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D) Rigid Gas Permeable Contact Lenses for Corneal Refractive Therapy for Temporary Myopic Refractive Power Reduction

Key Details

Gender

All

Age Range

8 Years - Any

Study Type

INTERVENTIONAL

Enrollment

250

Start Date

2019-08-29

Completion Date

2020-12-31

Last Updated

2019-12-05

Healthy Volunteers

Yes

Conditions

Interventions

DEVICE

Paragon CRT®100 Contact Lens

Paragon CRT® 100 Contact Lenses for Corneal Refractive Therapy are indicated for use in the reduction of myopic refractive error in nondiseased eyes.

Locations (4)

Changsha Aier Eye Hospital

Shanghai, China

Eye & ENT Hospital of Fudan University

Shanghai, China

Tianjin Eye Hospital

Tianjin, China

The Affiliated Eye Hospital of Wenzhou Medical University

Wenzhou, China